Fierce Pharma February 6, 2024
Two days ahead of a Senate hearing in which CEOs from three pharma majors will testify, Sen. Bernie Sanders, I-Vermont, has released (PDF) a report shedding light on the system that allows the companies to charge more for drugs in the U.S. than in any other country.
The report (PDF), from the Senate Committee on Health, Education, Labor and Pensions (HELP), zeroes in on the three companies that will be under fire on Thursday. Scheduled to appear are CEOs Chris Boerner of Bristol Myers Squibb, Joaquin Duato of Johnson & Johnson and Robert Davis of Merck & Co.
Among the findings highlighted by the HELP Committee were that in 2022, J&J and BMS each spent $3.2 billion more on stock...
Today's Sponsors
Today's Sponsor